Wordt geladen...
The future of intravenous iron in nephrology
Management of anaemia in chronic kidney disease (CKD) patients can be difficult and expensive. The recently completed Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT), the largest double-blinded trial of erythropoiesis-stimulating agents (ESA) treatment in CKD to date, provides us...
Bewaard in:
| Gepubliceerd in: | NDT Plus |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4813792/ https://ncbi.nlm.nih.gov/pubmed/27045558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndtplus/sfr040 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|